WO2002054070A1 - Puces proteiques, leur procede de production, leur systeme de detection et le procede de mise en route du systeme de detection - Google Patents
Puces proteiques, leur procede de production, leur systeme de detection et le procede de mise en route du systeme de detection Download PDFInfo
- Publication number
- WO2002054070A1 WO2002054070A1 PCT/CN2001/001294 CN0101294W WO02054070A1 WO 2002054070 A1 WO2002054070 A1 WO 2002054070A1 CN 0101294 W CN0101294 W CN 0101294W WO 02054070 A1 WO02054070 A1 WO 02054070A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- chip
- protein chip
- proteins
- detection system
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
Definitions
- the invention relates to a protein chip for multi-parameter parallel detection, a preparation method and a use method thereof. Background technique
- Biochip technology is an emerging biotechnology that emerged in the mid-1990s. Because it can perform parallel analysis of multiple types of information in one reaction, it has attracted the attention of many researchers and has been rapidly applied in many biological fields.
- Biochip technology is classified according to the detection object, and is mainly divided into two types: gene chip and protein chip. Since the gene chip plays an important role in the research work of the Human Genome Project, this technology has been greatly developed in just a few years. At present, the human genome project is about to be completed, and the research focus of biological sciences is about to shift from genomic research to proteomic research. As a result, many technology-leading laboratories have shifted their research focus to functional studies of known genes in the human genome.
- One of the technical problems to be solved by the present invention is to provide a protein chip for parallel detection of multiple indicators
- the second technical problem to be solved by the present invention is to provide a method for preparing the above-mentioned protein chip
- the third technical problem to be solved by the present invention is to provide the above-mentioned protein chip detection system
- the fourth technical problem to be solved by the present invention is to provide a method for using the protein chip detection system.
- the preparation principle of the protein chip for multi-parameter parallel detection according to the invention is as follows:
- the protein can be bound to the solid phase carrier by means of physical adsorption or covalent bonding, a variety of proteins can be immobilized on the solid phase carrier at a high density using a chip automatic spotting system;
- the unfixed protein region on the solid phase carrier can randomly adsorb proteins and other small molecules, which affects the detection accuracy of the protein chip. Therefore, a specific blocking solution is required to seal off the non-spotted parts of the solid phase carrier;
- the manufacturing method of the protein chip for parallel detection of multi-finger salamander according to the present invention is as follows:
- the protein chip for multi-indicator parallel detection has the following characteristics: 1)
- the solid support is an inorganic substrate or an organic compound substrate, and the inorganic substrate includes a semiconductor Silicon wafers, glass wafers, microporous silicon wafers, microporous glass, etc. are preferred glass sheets; organic substrates include cellulose acetate films, nitrocellulose films, nylon films, polypropylene films, etc., and nitrocellulose films are preferred.
- Proteins can be antigens, antibodies, receptors, ligands, etc., and further refer to proteins that can specifically bind to disease marker proteins in the body, especially tumor marker proteins.
- the receptors are biological macromolecules that can recognize and bind biologically active molecules (drugs, toxins, neurotransmitters and hormones, antigens and cell adhesion molecules, etc.) on or in the cell membrane. They can pass information generated by biologically active molecules to effectors, thereby causing corresponding biological effects. Most of these biological macromolecules are proteins, and some are glycolipids.
- Ligands are biologically active molecules that can specifically bind to receptors (ie drugs, toxins, neurotransmitters and hormones, antigens and cell adhesion molecules, etc.).
- the receptors and ligands referred to in the present invention are proteins.
- Coating solution CBS (NaHC0 3 -Na 2 C0 3 ) with a pH of 9.0-10.0 (optimal 9.6).
- the function of the coating solution is to provide a certain pH range, so that the chemical reaction or physical adsorption reaction between the protein and the solid support can be better combined in the liquid phase.
- the blocking solution contains 0.1-0.5% Tween 20, 0.02-0.3% tyrosine, 1- 93 ⁇ 4 sucrose, 1-9% BSA, 0.1% Prolin TBS (0.7-0.9% NaCl. 1. 0-1.5% Tis), the best is TBS containing 0.2 Tween 20, 0.1% tyrosine, 4% sucrose, 5% BSA, 0.5% proclin.
- TBS containing 0.2 Tween 20, 0.1% tyrosine, 4% sucrose, 5% BSA, 0.5% proclin.
- Tyrosine and BSA have a blocking effect, proclin can be preserved, sucrose is an inert substance and can block the air, and BSA and sucrose can be used as materials to support the frame structure.
- the blocking solution prevents the other parts of the solid phase carrier from binding to proteins, thereby ensuring the accuracy of the experimental data.
- the present invention also tried several other blocking solutions: one is TTBS-0.1% (V / V) Tween20 TBS, 10% TBS with 4 milk points, TTBS with 0.2% protein. References are: Bejurrum and Schater-Nielsen, 1986; Gillespie and Hudspeth>1991; Harlow and Lane>1988; Schneppenheim et al., 1991. The other is 5% (W / V) skimmed milk powder in PBS. References are: Molecular Cloning: A Laboratory Manual (2nd ed): J. sambrook, EFFritsch T. Maniatis.
- the object of the present invention for detection is various body fluids, so the materials are convenient to obtain and the stimulation to the patient is small.
- the detection principle of the protein chip provided by the present invention is: different proteins (abbreviated as B) produced on the protein chip can be specifically combined with corresponding proteins (abbreviated as A) contained in body fluids, tissues, cells, etc.
- the bound protein complex (BA) can bind another specific binding protein (C) for the corresponding protein (A).
- C has been labeled with peroxidase (C-labeled), so it forms a quadruple Complex (BAC-labeled).
- This peroxidase can catalyze a chemiluminescence reaction, and the intensity of the light signal generated can be detected only quantitatively by specific biochip detection. Therefore, the content of protein (A) contained in the body can be detected by the intensity of the detected light signal.
- the protein chip detection system for multi-index parallel detection according to the present invention includes:
- a protein chip for parallel detection of multiple indicators (1) A protein chip for parallel detection of multiple indicators
- the method of using the protein chip detection system for multi-parameter parallel detection according to the present invention is as follows:
- the protein chip detection system for multi-parameter parallel detection has the following characteristics: Unless otherwise specified, the following concentration units are W / V.
- a multi-protein mixed solution is a mixed solution of a plurality of peroxidase-labeled proteins that can specifically bind to a protein detected in a body fluid in a stable solution.
- the marker may be peroxidase, and further peroxidase is horseradish peroxidase.
- the washing solution contains 0.7-0.
- the preferred formula is 0.9% NaCl, 1.21% Tris, 0.1% Tween 20, and the pH is 7.50.
- the diluent contains (7-0.93 ⁇ 4NaCl, 1.0-1.5% Tris, 0.05-0.2% Tween 20, 0.05-0.2% road acid. Among them, the preferred S-square is 0.93 ⁇ 4NaCl. 1.21% Tris , 0.1% Tween 20, 0.1% tyrosine.
- Stable solution formula is 70-80% A solution (V / V) + 5- 20% ethylene glycol (V / V) + 1-9% sucrose (W / V) + 0. ll proclin (V / V ) + 0.05-0.5% EDTA.2Na (A solution contains 40-60% 0.05 M PBS (pH 7.2) and 40-60% fetal calf serum).
- Optimal formula 80% A solution (V / V) + 19% ethylene glycol (V / V) + 3% sucrose (W / V) + 0.5% proclin (V / V) + 0.% EDTA-2Na, (A solution contains 60% 0.05 M PBS (pH 7.2) and 40% fetal calf serum).
- a series of standards refers to a mixture of a variety of different concentrations of the test protein. It is prepared by mixing the test protein (which should be detected in body fluids) corresponding to each protein on the protein chip. This standard can be used with A variety of proteins on the protein chip are bound, and after the reaction steps described in the above use method, each protein position on the protein chip will be detected with a certain light signal intensity. If a standard in the detection system is used as a control, there is a significant signal difference between the test sample and the standard, indicating that the finger is positive. Reconstitute the standard with deionized water before use.
- compositions for generating chemiluminescence reactions There are two types of chemiluminescence reactions: ordinary chemiluminescence and enhanced Chenmiluminescence.
- the present invention uses an enhanced chemiluminescence reaction.
- the reagents involved in the reaction are Luminol (5-amino-2, 3-dihydro-1, 4-phthalazinedione Sodium Salt), H 2 0 2 (hydrogen peroxide), Enhancer (Eosin-eosin or PIP-p-iodophenol ), Peroxide (such as horseradish peroxidase HRP), were purchased from Sigma.
- a significant advantage of the protein chip for parallel detection of multiple indicators according to the present invention is the simultaneous introduction of multiple disease indicators, which greatly increases the accuracy of detection.
- Most of the existing disease indicators are non-specific indicators. Not only does the content of multiple markers increase significantly in the same disease at the same time, but the content of the same marker also increases in multiple diseases. This situation causes disease diagnosis. Difficulty leads to misdiagnosis.
- the existing disease marker proteins are non-specific indicators, and even the recognized primary liver cancer indicator AFP (alpha-fetoprotein)
- AFP alpha-fetoprotein
- the detection rate of liver cancer is only about 70%, and AFP is also significantly increased in the serum of some patients with testicular cancer, teratoma, gastric cancer, and pancreatic cancer. Therefore, the necessity of joint detection of multiple species is proposed.
- the detection rate of CA19-9 is about 60%, plus CA125, CA50 and DU-PAN-, the detection rate can be mentioned above 90%.
- Another example is lung cancer: CEA alone has a higher specificity for the diagnosis of lung cancer, but if NSE, sialic acid, CEA, and SCC are added, the specificity is higher.
- Another advantage of the protein chip for multi-parameter parallel detection according to the present invention is high sensitivity.
- the use of chemiluminescence reaction and enhanced luminescence reaction enables the protein chip to detect target proteins with only lpg per ml of body fluid, which makes some Protein fingers with high specificity but low content in body fluids can be used for clinical detection, thereby expanding the selection range of clinical detection indicators.
- protein chips can provide efficient, convenient, and accurate clinical detection methods for modern medical diagnostics. It is of great significance for the diagnosis of difficult diseases and the early diagnosis and timely treatment of malignant diseases such as tumors. Since proteins are closer to the material level of life than genes, protein chips have more direct application prospects in life science related fields such as disease diagnosis and treatment, new drug development, and exploring molecular mechanisms of diseases.
- the compliance status of the protein chip detection system of the present invention is:
- Sensitivity true positive / (true positive + false negative)> 80%;
- the lower limit of detection is 10-12 g / L for serum samples.
- Stability Stable for 2 years at 4 ° C; Stable for 1 week at 37 ° C.
- FIG. 1 is a schematic diagram of the results of a standard blood sample detected by the protein chip of the present invention
- FIG. 2 is a schematic diagram of blood sample results of liver cancer patients detected by the protein chip of the present invention. The best way to implement the invention
- Example 1 Preparation of a protein chip
- Solid support nitrocellulose membrane.
- Proteins used on solid-phase carriers Monoclonal antibodies to detect tumor marker proteins, the amount used is 5 ng, and the spot density is 25 dots / 0.36 cm 2 .
- Spots are Al, A2—CA153 antibody, A3, A4—CA19-9 antibody, A5—negative control, Bl, B2—CA125 antibody, B3, C4—AFF antibody, CI, C2—CA125 antibody, C3, B4— beta-HCG antibody, B5, C5—CA19-5 antibody, Dl, D2—PSA antibody, D3, E4—CEA antibody, El, E2—PSA antibody, E3, D4—CA15-3 antibody, D5, E5—CA549 antibody .
- Antibodies were purchased from Fitzgerald, CanAg.
- AFP alpha-fetoprotein
- CEA carcinoembryonic antigen
- PSA prostate specific antigen
- betaHCG human chorionic gonadotropin beta subunit
- CA carbohydrate antigens
- Coating solution CBS (NaHC0 3 -Na 2 C0 3 ), pH 9.6.
- Blocking solution 0.9 NaCl. 1.21% Tris, 0.2% Tween 20. 0.1% tyrosine, 4% sucrose, 5% BSA, 0.5% proclin.
- Example 2 Detection of protein A blood sample of a normal human (see FIG. 1) and a blood sample of a liver cancer patient (see FIG. 2) are compared using the protein chip of the present invention.
- the advantages and application prospects of the invention are very obvious.
- the use of the protein chip of the present invention greatly improves the accuracy of detection, and has the advantages of high reliability and high detection sensitivity, and can be widely used in molecular biology, biomedicine, and human proteome research, especially for clinical diagnosis.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01982082A EP1348961A4 (en) | 2001-01-04 | 2001-08-30 | PROTEIN CHIPS, METHOD OF MANUFACTURING THEREOF, AND PROBLEM SYSTEM FOR PROTEIN CHIPS AND OPERATING PROCESS FOR THE SEALING SYSTEM |
CA002428428A CA2428428A1 (en) | 2001-01-04 | 2001-08-30 | Protein chips, method producing it and detection system of the protein chips, and operating method of the detection system |
JP2002554717A JP2004516489A (ja) | 2001-01-04 | 2001-08-30 | 蛋白チップ、その作製方法、該蛋白チップを使用する検出システムおよび該検出システムを使用する方法 |
US10/464,127 US20030228631A1 (en) | 2001-01-04 | 2003-06-18 | Protein chips, method producing it and detection system of the protein chips, and operating method of the detection system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01105023.3 | 2001-01-04 | ||
CN01105023.3A CN1217194C (zh) | 2001-01-04 | 2001-01-04 | 蛋白芯片及其制备方法和使用方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/464,127 Continuation US20030228631A1 (en) | 2001-01-04 | 2003-06-18 | Protein chips, method producing it and detection system of the protein chips, and operating method of the detection system |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002054070A1 true WO2002054070A1 (fr) | 2002-07-11 |
Family
ID=4654111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2001/001294 WO2002054070A1 (fr) | 2001-01-04 | 2001-08-30 | Puces proteiques, leur procede de production, leur systeme de detection et le procede de mise en route du systeme de detection |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030228631A1 (zh) |
EP (1) | EP1348961A4 (zh) |
JP (1) | JP2004516489A (zh) |
CN (1) | CN1217194C (zh) |
CA (1) | CA2428428A1 (zh) |
WO (1) | WO2002054070A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005033307A1 (ja) * | 2003-09-30 | 2005-04-14 | Kyowa Hakko Kogyo Co., Ltd. | 新規のリフォールディング方法およびその方法によって得られたタンパク質 |
EP1560023A1 (en) * | 2002-10-24 | 2005-08-03 | Shanghai Health Digit Co. Limited | A protein chips detecting system which can simultaneously detect multi target |
US7442773B2 (en) | 2004-01-23 | 2008-10-28 | The Board Of Trustees Of The University Of Illinois | Universal peptide-binding scaffolds and protein chips |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1164948C (zh) * | 2002-06-06 | 2004-09-01 | 成都夸常科技有限公司 | 一种基于抗原抗体反应的试剂盒 |
CN100504395C (zh) * | 2003-07-18 | 2009-06-24 | 上海数康生物科技有限公司 | Sars病毒诊断试剂 |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
JP4862412B2 (ja) * | 2006-01-31 | 2012-01-25 | 住友ベークライト株式会社 | バイオチップの製造方法 |
US20080200342A1 (en) * | 2007-02-15 | 2008-08-21 | Rao Rupa S | Device, Array, And Methods For Disease Detection And Analysis |
WO2008122241A1 (en) * | 2007-04-04 | 2008-10-16 | Diagcor Bioscience Incorporation Limited | Rapid protein analyses and the device thereof |
CN101126759B (zh) * | 2007-09-21 | 2011-05-11 | 王琳 | 塑料试管蛋白芯片、其制备方法及应用 |
CN101477117B (zh) * | 2009-01-16 | 2012-12-19 | 中国农业科学院哈尔滨兽医研究所 | 检测禽病血清抗体的可视化蛋白芯片及其制备方法和应用 |
CN102175860A (zh) * | 2010-12-15 | 2011-09-07 | 中国疾病预防控制中心寄生虫病预防控制所 | 一种检测寄生虫病的蛋白芯片及其试剂盒和制备方法 |
CN102141569A (zh) * | 2010-12-15 | 2011-08-03 | 中国疾病预防控制中心寄生虫病预防控制所 | 一种用于联合诊断三种吸虫病的蛋白芯片及其制备方法 |
CN102621301B (zh) * | 2011-01-28 | 2014-10-08 | 上海铭源数康生物芯片有限公司 | 一种基于硝酸纤维素膜的蛋白芯片封闭液的制备方法 |
CN102676640B (zh) * | 2011-03-10 | 2014-11-26 | 国家纳米科学中心 | 催化复合物及可视化检测方法 |
CN102830233B (zh) * | 2011-06-13 | 2015-08-26 | 上海铭源数康生物芯片有限公司 | 一种基于硝酸纤维素膜的elisa反应方法 |
CN102621330A (zh) * | 2012-04-05 | 2012-08-01 | 中国疾病预防控制中心营养与食品安全所 | 用于检测人体铁储量的蛋白芯片及其试剂盒 |
CN102645530B (zh) * | 2012-04-06 | 2014-06-18 | 上海蓝怡科技有限公司 | 甲状腺素酶联免疫体外诊断试剂盒中酶结合物稀释液的制备方法 |
JP6652916B2 (ja) * | 2013-06-20 | 2020-02-26 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 膵臓がんを診断するための方法 |
CN107782721A (zh) * | 2016-08-26 | 2018-03-09 | 韦彦余 | 一种基于膜的生物样品化学发光检测方法和相关检测试剂盒 |
CN107238703A (zh) * | 2017-07-19 | 2017-10-10 | 陈剑桃 | 一种可检测6种养殖鱼类细菌性疾病的抗体芯片 |
CN108593939B (zh) * | 2018-07-18 | 2023-11-14 | 瑞博奥(广州)生物科技股份有限公司 | 一种全自动蛋白芯片及其应用 |
CN111239412A (zh) * | 2020-01-20 | 2020-06-05 | 复旦大学附属中山医院 | 聚焦肝细胞肝癌的蛋白小芯片的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998015834A1 (en) * | 1996-10-07 | 1998-04-16 | Schering Corporation | ASSAY FOR THE DETECTION OF ANTIBODIES AGAINST p53 |
US5874219A (en) * | 1995-06-07 | 1999-02-23 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
EP1041385A2 (en) * | 1999-03-30 | 2000-10-04 | Fuji Photo Film Co., Ltd. | Method and apparatus for detecting an organism-originated substance |
CN1274085A (zh) * | 2000-04-13 | 2000-11-22 | 陈学银 | 一种蛋白芯片及其制备方法并用其筛选单克隆抗体 |
CN1274758A (zh) * | 1999-05-21 | 2000-11-29 | 陆祖宏 | 制备化合物微阵列芯片的方法及由该方法制备的化合物微阵列芯片 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6447952A (en) * | 1987-05-06 | 1989-02-22 | Saibaafuruua Inc | Immunoassay, reagent used therefor and making thereof |
IL99630A0 (en) * | 1991-10-02 | 1992-08-18 | Channa Shalitin | Novel antibodies useful for the detection of benign and malignant tumors |
US5610021A (en) * | 1992-02-21 | 1997-03-11 | Creative Biomolecules, Inc. | Compositions and methods for identification and use of soluble complex forms of osteogenic proteins |
US5494829A (en) * | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
US5922533A (en) * | 1997-08-15 | 1999-07-13 | Abbott Laboratories | Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups |
US6531305B1 (en) * | 1998-09-10 | 2003-03-11 | University Of Massachusetts | Sperm associated protein kinase polypeptides, corresponding nucleic acids, and methods of use |
US6599713B1 (en) * | 1999-03-29 | 2003-07-29 | Asahi Kasei Kabushiki Kaisha | Method for quantitating leukocyte count in whole blood sample |
KR20000071894A (ko) * | 1999-08-19 | 2000-12-05 | 김선영 | 단백질칩 및 이를 이용한 다목적 자동화 진단시스템 |
US6855538B2 (en) * | 2001-06-27 | 2005-02-15 | The Regents Of The University Of California | High-efficiency microarray printing device |
-
2001
- 2001-01-04 CN CN01105023.3A patent/CN1217194C/zh not_active Expired - Lifetime
- 2001-08-30 EP EP01982082A patent/EP1348961A4/en not_active Withdrawn
- 2001-08-30 WO PCT/CN2001/001294 patent/WO2002054070A1/zh not_active Application Discontinuation
- 2001-08-30 CA CA002428428A patent/CA2428428A1/en not_active Abandoned
- 2001-08-30 JP JP2002554717A patent/JP2004516489A/ja active Pending
-
2003
- 2003-06-18 US US10/464,127 patent/US20030228631A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874219A (en) * | 1995-06-07 | 1999-02-23 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
WO1998015834A1 (en) * | 1996-10-07 | 1998-04-16 | Schering Corporation | ASSAY FOR THE DETECTION OF ANTIBODIES AGAINST p53 |
EP1041385A2 (en) * | 1999-03-30 | 2000-10-04 | Fuji Photo Film Co., Ltd. | Method and apparatus for detecting an organism-originated substance |
CN1274758A (zh) * | 1999-05-21 | 2000-11-29 | 陆祖宏 | 制备化合物微阵列芯片的方法及由该方法制备的化合物微阵列芯片 |
CN1274085A (zh) * | 2000-04-13 | 2000-11-22 | 陈学银 | 一种蛋白芯片及其制备方法并用其筛选单克隆抗体 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1560023A1 (en) * | 2002-10-24 | 2005-08-03 | Shanghai Health Digit Co. Limited | A protein chips detecting system which can simultaneously detect multi target |
EP1560023A4 (en) * | 2002-10-24 | 2007-08-01 | Shanghai Health Digit Co Ltd | PROTEIN CHIP DETECTION SYSTEM WHICH CAN DETECT A MULTIPLE TARGET AT THE SAME TIME |
WO2005033307A1 (ja) * | 2003-09-30 | 2005-04-14 | Kyowa Hakko Kogyo Co., Ltd. | 新規のリフォールディング方法およびその方法によって得られたタンパク質 |
US7442773B2 (en) | 2004-01-23 | 2008-10-28 | The Board Of Trustees Of The University Of Illinois | Universal peptide-binding scaffolds and protein chips |
Also Published As
Publication number | Publication date |
---|---|
CN1363840A (zh) | 2002-08-14 |
EP1348961A4 (en) | 2006-06-28 |
CA2428428A1 (en) | 2002-07-11 |
JP2004516489A (ja) | 2004-06-03 |
US20030228631A1 (en) | 2003-12-11 |
EP1348961A1 (en) | 2003-10-01 |
CN1217194C (zh) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002054070A1 (fr) | Puces proteiques, leur procede de production, leur systeme de detection et le procede de mise en route du systeme de detection | |
CN100386627C (zh) | 过滤型蛋白芯片 | |
US8530230B2 (en) | Multiplexed assay methods | |
JP2018054629A (ja) | コバインダー補助アッセイ法 | |
CA2408094A1 (en) | Colloid compositions for solid phase biomolecular analytical, preparative and identification systems | |
CN105785026B (zh) | 用于检测肠道病毒71型IgM抗体的试剂盒及检测方法 | |
CN102721813A (zh) | 前列腺特异抗原均相发光免疫分析检测试剂盒及其检测方法 | |
RU2298796C2 (ru) | Диагностическая система, содержащая белковые чипы и выполненная с возможностью одновременного определения множества показателей | |
JP2005504988A (ja) | 較正マイクロアレイ | |
RU2682721C2 (ru) | Биологический микрочип для обнаружения опухолевых экзосом в сыворотке крови человека для диагностики колоректального рака | |
EP4119945A1 (en) | Highly sensitive immunoconjugate, preparing method thereof, in vitro diagnostic reagent and in vitro diagnostic kit including the same | |
CN105675878B (zh) | 可用于诊断人肠道病毒71型感染的试剂盒及诊断方法 | |
CN105784997B (zh) | 用于检测肠道病毒71型IgM抗体的试剂盒及检测方法 | |
CN1865994B (zh) | 含有机分子交联标记的分析方法及与之相关的分析组成 | |
CN107255713A (zh) | 可用于诊断人肠道病毒感染的试剂盒 | |
JP4207754B2 (ja) | 磁性体を用いた免疫学的測定方法 | |
JP2007085779A (ja) | マイクロチップを用いた生物学的物質の分析方法及び分析キット | |
Ito | Microarray Chips (in Vitro Diagnosis) | |
CN113945713A (zh) | 用于多种肿瘤标志物联合检测的生物芯片及其制备与应用 | |
CN117388499A (zh) | 血清中抗原类蛋白的化学发光蛋白芯片方法和试剂盒 | |
TW201131158A (en) | Biochemical detection unit and biochemical device having the same | |
Ricchiuti | IMMUNOASSAY-BASED TECHNOL-OGIES F OR THE MEASUREMENT OF BIOLOGICAL MATERIALS USED FOR BIOMARKERS DISCOVERY AND TRANSLATIONAL RESEARCH | |
CN116445592A (zh) | 一种改进的elisa测试方法 | |
CN101126759A (zh) | 塑料试管蛋白芯片、其制备方法及应用 | |
JP2021525376A (ja) | 化学発光免疫分析測定法及び該方法を使用するシステム、試薬キット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2428428 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10464127 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002554717 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001982082 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001982082 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001982082 Country of ref document: EP |